H. Lode (Berlin, Germany)
Disorders of the mineral metabolism in patients with tuberculosis
E. Kulchavenya, E. Brizhatyuk (Novosibirsk, Russian Federation)
|  |
Laser therapy for urogenital tuberculosis
E. Kulchavenya (Novosibirsk, Russian Federation)
| |
Evaluation of D-dimer levels in patients with active pulmonary tuberculosis and latent tuberculosis infection
E. C. Seyhan, E. Cetinkaya, S. Altin, L. Karasulu, P. Ozkan (Istanbul, Turkey)
| |
Relation of D-dimer levels and extent of disease in patients with active tuberculosis infection
E. C. Seyhan, S. Altin, E. Cetinkaya, S. Timur, N. Simsek (Istanbul, Turkey)
| |
Tuberculosis in patients with chronic renal failure
C. E. Horodniceanu, A. Covic (Iasi, Romania)
| |
Cause of death in tuberculosis – epidemiologic study in Cluj county
M. O. Man, M. I. Pop, D. I. Todea, R. V. Rajnoveanu, A. N. Rajnoveanu (Cluj Napoca, Romania)
| |
Basic assumptions in tuberculosis treatment in pregnancy
G. Mrcic-Martinovic (Belgrade, Serbia And Montenegro)
| |
The etiology of solitary pulmonary nodules in young patients
O. Deniz, S. Gumus, F. Ciftci, O. Yucel, F. Ors, O. Onguru, E. Tozkoparan, O. Genc, H. Bilgic, K. Ekiz (Ankara, Istanbul, Turkey)
| |
Clinical and radiological characteristics of pulmonary tuberculosis in Tunisian diabetic patients
I. Aissa, S. Aouadi, Z. Moatemri, F. Makki, A. Khattab, H. Ghedira (Ariana, Tunisia)
| |
Peculiarities of community-acquired pneumonia course, caused by multiresistant strains of S. pneumoniae
V. N. Turkutjukov, V. A. Nevzorova, I. M. Martynenko, A. V. Martynova (Vladivostok, Russian Federation)
| |
Features of community acquired pneumonia in patients hospitalized in the institute for pulmonary diseases over a five-year period
M. D. Djuric, D. Povazan, N. G. Secen, V. Kosjerina (Sremska Kamenica, Serbia And Montenegro)
| |
Retrospective audit of community acquired pneumonia (CAP) in adults admitted to a district general hospital in England
M. Fayaz, R. Ellis, M. Bone (South Shields, United Kingdom)
| |
Lymphotropic therapy of community acquired pneumonias associated with pulmonary destruction
V. A. Bauer, A. V. Bondarenko, T. S. Ageeva (Tomsk, Russian Federation)
| |
Effectiveness of empirical treatment of community acquired pneumonia requiring hospitalization
E. Danila, R. Nargela, V. Sileikiene, Z. Logunova (Vilnius, Lithuania)
| |
Use of respiratory fluoroquinolones gatifloxacin for treatment of severe community-acquired pneumonia (SCAP)
Y. M. Mostovoy, H. V. Demchuk, T. V. Konstantinovich, N. S. Slepchenko (Vinnitsa, Ukraine)
| |
Non-tuberculous mycobacteriosis
M. O. Man, M. I. Pop, D. I. Todea, R. V. Rajnoveanu, M. I. Goron (Cluj Napoca, Baia Mare, Romania)
| |
Comparison of different models of azithromycin treatment of patients with no severe community-acquired pneumonia
H. V. Demchuk, Y. M. Mostovoy, L. V. Rasputina (Vinnitsa, Ukraine)
| |
Plasma endothelin-1 levels in septic patients
M. Piechota, R. Irzmanski, M. Banach, M. Barylski, M. Piechota-Urbanska, J. Rysz, P. K. Okonski, J. Kowalski, L. Pawlicki (Lodz, Poland)
| |
Lung aspergilosis with obturation of pulmonary artery
D. G. Valev, T. L. Mondeshki, D. S. Petrova, O. B. Georgiev (Sofia, Bulgaria)
| |
Helminthic right hydrothorax in a male 45 with pleural mesothelioma
M. A. Nzegwu, C. J. Chukwuka, O. Okafor, D. B. Olusina, C. Onyedum (Enugu, Nigeria)
| |